Skip to main content
Journal cover image

Positive margins: is adjunctive radiation therapy indicated?

Journal articles  - Journal Article
Paulson, DF; Robertson, CN
Published in: Acta Oncol
1991

Patients with margin positive disease after radical prostatectomy are prognostically disadvantaged. The question of postoperative adjunctive radiotherapy in these patients is controversial. A retrospective study suggested that adjunctive radiation therapy reduced the local recurrence rate but did not alter survival.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Acta Oncol

DOI

ISSN

0284-186X

Publication Date

1991

Volume

30

Issue

2

Start / End Page

263 / 265

Location

Sweden

Related Subject Headings

  • Survival Rate
  • Prostatic Neoplasms
  • Oncology & Carcinogenesis
  • Neoplasm Recurrence, Local
  • Male
  • Humans
  • Combined Modality Therapy
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Paulson, D. F., & Robertson, C. N. (1991). Positive margins: is adjunctive radiation therapy indicated? Acta Oncol, 30(2), 263–265. https://doi.org/10.3109/02841869109092366
Paulson, D. F., and C. N. Robertson. “Positive margins: is adjunctive radiation therapy indicated?Acta Oncol 30, no. 2 (1991): 263–65. https://doi.org/10.3109/02841869109092366.
Paulson DF, Robertson CN. Positive margins: is adjunctive radiation therapy indicated? Acta Oncol. 1991;30(2):263–5.
Paulson, D. F., and C. N. Robertson. “Positive margins: is adjunctive radiation therapy indicated?Acta Oncol, vol. 30, no. 2, 1991, pp. 263–65. Pubmed, doi:10.3109/02841869109092366.
Paulson DF, Robertson CN. Positive margins: is adjunctive radiation therapy indicated? Acta Oncol. 1991;30(2):263–265.
Journal cover image

Published In

Acta Oncol

DOI

ISSN

0284-186X

Publication Date

1991

Volume

30

Issue

2

Start / End Page

263 / 265

Location

Sweden

Related Subject Headings

  • Survival Rate
  • Prostatic Neoplasms
  • Oncology & Carcinogenesis
  • Neoplasm Recurrence, Local
  • Male
  • Humans
  • Combined Modality Therapy
  • 3211 Oncology and carcinogenesis